Mercer Global Advisors
TARS icon

Mercer Global Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Mercer Global Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
+2,431
New +$155K ﹤0.01% 3490

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mercer Global Advisors's TARS Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Tarsus Pharmaceuticals (TARS) in Q2 2026: 2,431 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #3490 among its holdings.

234 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Mercer Global Advisors held 2,431 shares of Tarsus Pharmaceuticals worth $153K as of Q2 2026.
  • Tarsus Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3490 holding.
  • 234 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.